Application of mifepristone in the treatment of perimenopausal dysfunctional uterine bleeding
10.3760/cma.j.issn.1008-6706.2013.10.022
- VernacularTitle:米非司酮在围绝经期功能失调性子宫出血治疗中的应用
- Author:
Zhihong YANG
- Publication Type:Journal Article
- Keywords:
Perimenopausal;
Dysfunctional uterine bleeding;
Mifepristone;
Menopause;
Treatment
- From:
Chinese Journal of Primary Medicine and Pharmacy
2013;20(10):1489-1490
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore an effective treatment for perimenopausal dysfunctional uterine bleeding.Methods 136 patients with perimenopausal dysfunctional uterine bleeding were received mifepristone treatment.Hemoglobin,thickness of the endometrium and sex hormones indicators,including progesterone (P),estrogen (E2),the corpus luteum generated hormone(LH),follicle hormone(FSH),prolactin(PRL) and testosterone(T),were detected before and after treatment.Results The treatment effective rate was 89.7％.After taking a course of treatment,89 cases decreased to restore normal menstrual cycle ;33 cases entered menopause after taking a course of treatment.After treatment,hemoglobin level was significantly increased compared with before treatment (t =3.899,P ＜ 0.05),and endometrial thickness significantly reduced (t =5.652,P ＜ 0.05).After treatment,the P,E2,FSH,LH levels were significantly lower than before treatment(t =5.320,4.309,3.872,3.641,all P ＜ 0.05).T,PRL levels had no significant differences.Conclusion The mifepristone treatment for perimenopausal uterine bleeding have good clinical efficacy,less adverse reactions,and worthy of clinical application.
